Literature DB >> 24779419

Huntington's disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem.

Udo Rüb1, Matthias Hentschel, Katharina Stratmann, Ewout Brunt, Helmut Heinsen, Kay Seidel, Mohamed Bouzrou, Georg Auburger, Henry Paulson, Jean-Paul Vonsattel, Herwig Lange, Horst-Werner Korf, Wilfred den Dunnen.   

Abstract

Huntington's disease (HD) is a progressive polyglutamine disease that leads to a severe striatal and layer-specific neuronal loss in the cerebral neo-and allocortex. As some of the clinical symptoms (eg, oculomotor dysfunctions) suggested a degeneration of select brainstem nuclei, we performed a systematic investigation of the brainstem of eight clinically diagnosed and genetically confirmed HD patients. This post-mortem investigation revealed a consistent neuronal loss in the substantia nigra, pontine nuclei, reticulotegmental nucleus of the pons, superior and inferior olives, in the area of the excitatory burst neurons for horizontal saccades, raphe interpositus nucleus and vestibular nuclei. Immunoreactive intranuclear neuronal inclusions were present in all degenerated and apparently spared brainstem nuclei and immunoreactive axonal inclusions were observed in all brainstem fiber tracts of the HD patients. Degeneration of brainstem nuclei can account for a number of less well-understood clinical HD symptoms (ie, cerebellar, oculomotor and vestibular symptoms), while the formation of axonal aggregates may represent a crucial event in the cascades of pathological events leading to neurodegeneration in HD.
© 2013 International Society of Neuropathology.

Entities:  

Keywords:  Huntington's disease; axonal inclusions; brainstem; neurodegeneration; pathoanatomy; polyglutamine diseases

Mesh:

Substances:

Year:  2014        PMID: 24779419      PMCID: PMC4160739          DOI: 10.1111/bpa.12115

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  76 in total

Review 1.  The ubiquitin-proteasome system in Huntington's disease.

Authors:  A G Valera; M Díaz-Hernández; F Hernández; Z Ortega; J J Lucas
Journal:  Neuroscientist       Date:  2005-12       Impact factor: 7.519

Review 2.  Huntington's disease genetics.

Authors:  Richard H Myers
Journal:  NeuroRx       Date:  2004-04

Review 3.  Huntington's Disease.

Authors:  Francis O Walker
Journal:  Semin Neurol       Date:  2007-04       Impact factor: 3.420

4.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

5.  Nerve cell loss in the thalamic mediodorsal nucleus in Huntington's disease.

Authors:  H Heinsen; U Rüb; M Bauer; G Ulmar; B Bethke; M Schüler; F Böcker; W Eisenmenger; M Götz; H Korr; C Schmitz
Journal:  Acta Neuropathol       Date:  1999-06       Impact factor: 17.088

Review 6.  Functional neuroanatomy of the human premotor oculomotor brainstem nuclei: insights from postmortem and advanced in vivo imaging studies.

Authors:  Udo Rüb; Joanna C Jen; Heiko Braak; Thomas Deller
Journal:  Exp Brain Res       Date:  2008-04-02       Impact factor: 1.972

7.  The p62 antibody reveals various cytoplasmic protein aggregates in spinocerebellar ataxia type 6.

Authors:  K Seidel; E R P Brunt; R A I de Vos; F Dijk; H J L van der Want; U Rüb; W F A den Dunnen
Journal:  Clin Neuropathol       Date:  2009 Sep-Oct       Impact factor: 1.368

8.  An immunofluorescence microscopical study of the neurofilament triplet proteins, vimentin and glial fibrillary acidic protein within the adult rat brain.

Authors:  G Shaw; M Osborn; K Weber
Journal:  Eur J Cell Biol       Date:  1981-12       Impact factor: 4.492

Review 9.  Huntington disease models and human neuropathology: similarities and differences.

Authors:  Jean Paul G Vonsattel
Journal:  Acta Neuropathol       Date:  2007-11-03       Impact factor: 17.088

Review 10.  Huntington's disease: from pathology and genetics to potential therapies.

Authors:  Sara Imarisio; Jenny Carmichael; Viktor Korolchuk; Chien-Wen Chen; Shinji Saiki; Claudia Rose; Gauri Krishna; Janet E Davies; Evangelia Ttofi; Benjamin R Underwood; David C Rubinsztein
Journal:  Biochem J       Date:  2008-06-01       Impact factor: 3.857

View more
  18 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

Review 2.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

3.  Calpain Inhibition Is Protective in Machado-Joseph Disease Zebrafish Due to Induction of Autophagy.

Authors:  Maxinne Watchon; Kristy C Yuan; Nick Mackovski; Adam J Svahn; Nicholas J Cole; Claire Goldsbury; Silke Rinkwitz; Thomas S Becker; Garth A Nicholson; Angela S Laird
Journal:  J Neurosci       Date:  2017-07-07       Impact factor: 6.167

Review 4.  Juvenile-Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review.

Authors:  Hannah S Bakels; Raymund A C Roos; Willeke M C van Roon-Mom; Susanne T de Bot
Journal:  Mov Disord       Date:  2021-10-12       Impact factor: 9.698

5.  Neurocardiovascular deficits in the Q175 mouse model of Huntington's disease.

Authors:  Tamara S Cutler; Saemi Park; Dawn H Loh; Maria C Jordan; Tomohiro Yokota; Kenneth P Roos; Cristina A Ghiani; Christopher S Colwell
Journal:  Physiol Rep       Date:  2017-06

Review 6.  Neuro-Cardio Mechanisms in Huntington's Disease and Other Neurodegenerative Disorders.

Authors:  Bethan J Critchley; Mark Isalan; Michal Mielcarek
Journal:  Front Physiol       Date:  2018-05-23       Impact factor: 4.566

Review 7.  Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.

Authors:  Gabor G Kovacs
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

8.  Proteomic Profiling of Cranial (Superior) Cervical Ganglia Reveals Beta-Amyloid and Ubiquitin Proteasome System Perturbations in an Equine Multiple System Neuropathy.

Authors:  Bruce C McGorum; R Scott Pirie; Samantha L Eaton; John A Keen; Elizabeth M Cumyn; Danielle M Arnott; Wenzhang Chen; Douglas J Lamont; Laura C Graham; Maica Llavero Hurtado; Alan Pemberton; Thomas M Wishart
Journal:  Mol Cell Proteomics       Date:  2015-09-13       Impact factor: 5.911

9.  Expression map of 78 brain-expressed mouse orphan GPCRs provides a translational resource for neuropsychiatric research.

Authors:  Aliza T Ehrlich; Grégoire Maroteaux; Anne Robe; Lydie Venteo; Md Taufiq Nasseef; Leon C van Kempen; Naguib Mechawar; Gustavo Turecki; Emmanuel Darcq; Brigitte L Kieffer
Journal:  Commun Biol       Date:  2018-08-06

10.  Computerised Dynamic Posturography in Premanifest and Manifest individuals with Huntington's Disease.

Authors:  Alvaro Reyes; Danielle Salomonczyk; Wei-Peng Teo; Luis D Medina; Danielle Bartlett; Eva Pirogovsky-Turk; Pauline Zaenker; Jody Corey Bloom; Roger W Simmons; Mel Ziman; Paul E Gilbert; Travis Cruickshank
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.